17-36493971-AAGAC-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004773.4(ZNHIT3):βc.255_258delβ(p.Asp85GlufsTer7) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000558 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.00018 ( 0 hom., cov: 33)
Exomes π: 0.000042 ( 0 hom. )
Consequence
ZNHIT3
NM_004773.4 frameshift
NM_004773.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.60
Genes affected
ZNHIT3 (HGNC:12309): (zinc finger HIT-type containing 3) Predicted to enable thyroid hormone receptor binding activity. Predicted to be involved in box C/D snoRNP assembly; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); and snoRNA localization. Located in cytoplasm and nucleus. Implicated in PEHO syndrome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNHIT3 | NM_004773.4 | c.255_258del | p.Asp85GlufsTer7 | frameshift_variant | 4/5 | ENST00000617429.5 | NP_004764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNHIT3 | ENST00000617429.5 | c.255_258del | p.Asp85GlufsTer7 | frameshift_variant | 4/5 | 1 | NM_004773.4 | ENSP00000484687 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152250Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
28
AN:
152250
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251372Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135856
GnomAD3 exomes
AF:
AC:
17
AN:
251372
Hom.:
AF XY:
AC XY:
10
AN XY:
135856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461406Hom.: 0 AF XY: 0.0000454 AC XY: 33AN XY: 727048
GnomAD4 exome
AF:
AC:
62
AN:
1461406
Hom.:
AF XY:
AC XY:
33
AN XY:
727048
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152368Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74518
GnomAD4 genome
AF:
AC:
28
AN:
152368
Hom.:
Cov.:
33
AF XY:
AC XY:
12
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 06, 2023 | Variant summary: ZNHIT3 c.255_258delCAGA (p.Asp85GlufsX7) results in a premature termination codon, which is expected to escape nonsense mediated decay. The variant allele was found at a frequency of 6.8e-05 in 251372 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ZNHIT3 causing PEHO Syndrome, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.255_258delCAGA in individuals affected with PEHO Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at